These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29876002)

  • 1. Evaluation of appropriate follow-up after curative surgery for patients with colorectal cancer using time to recurrence and survival after recurrence: a retrospective multicenter study.
    Yamano T; Yamauchi S; Tsukamoto K; Noda M; Kobayashi M; Hamanaka M; Babaya A; Kimura K; Son C; Imada A; Tanaka S; Ikeda M; Tomita N; Sugihara K;
    Oncotarget; 2018 May; 9(39):25474-25490. PubMed ID: 29876002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of 13-year survival of patients with colon and rectal cancers; lessons from Shiraz colorectal cancer surgery registry system of a level three medical center.
    Safarpour AR; Bananzadeh A; Izadpanah A; Ghahramani L; Tadayon SMK; Bahrami F; Hosseini SV
    BMC Surg; 2022 Apr; 22(1):142. PubMed ID: 35428290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in carcinoembryonic antigen levels between colon and rectal cancer.
    Ding Y; Xuan W; Chen C; Chen Z; Yang Z; Zuo Y; Ren S
    Mol Clin Oncol; 2014 Jul; 2(4):618-622. PubMed ID: 24940506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between colon and rectal cancer in complications, short-term survival and recurrences.
    van der Sijp MP; Bastiaannet E; Mesker WE; van der Geest LG; Breugom AJ; Steup WH; Marinelli AW; Tseng LN; Tollenaar RA; van de Velde CJ; Dekker JW
    Int J Colorectal Dis; 2016 Oct; 31(10):1683-91. PubMed ID: 27497831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage: A Retrospective Dutch Population-based Study.
    Arron MNN; Greijdanus NG; Bastiaans S; Vissers PAJ; Verhoeven RHA; Ten Broek RPG; Verheul HMW; Tanis PJ; van Goor H; de Wilt JHW
    Ann Surg; 2022 Nov; 276(5):882-889. PubMed ID: 35930021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    Tokodai K; Narimatsu H; Nishida A; Takaya K; Hara Y; Kawagishi N; Hashizume E; Ohuchi N
    J Surg Oncol; 2016 Sep; 114(3):368-74. PubMed ID: 27264681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III.
    Kim HS; Lee MR
    Ann Coloproctol; 2013 Aug; 29(4):155-9. PubMed ID: 24032116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
    Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
    Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
    Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
    Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer.
    Kleespies A; Füessl KE; Seeliger H; Eichhorn ME; Müller MH; Rentsch M; Thasler WE; Angele MK; Kreis ME; Jauch KW
    Int J Colorectal Dis; 2009 Sep; 24(9):1097-109. PubMed ID: 19495779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
    Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
    Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
    Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study.
    Qaderi SM; Galjart B; Verhoef C; Slooter GD; Koopman M; Verhoeven RHA; de Wilt JHW; van Erning FN
    Int J Colorectal Dis; 2021 Nov; 36(11):2399-2410. PubMed ID: 33813606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.